Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #17331 on Aurinia Pharmaceuticals Inc (AUPH)
Whalatane
02/16/24 6:52 PM
#17332 RE: rosemountbomber #17331
” Brad H. Rovin, MD, co-chair of the guideline review, said in a press release. “With ongoing trials evaluating additional novel therapeutics and promising new data on the horizon, the guideline sets the stage for future advancements in the management and treatment of LN.”